Your browser is no longer supported. Please, upgrade your browser.
Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Index- P/E- EPS (ttm)-2.05 Insider Own1.70% Shs Outstand119.49M Perf Week5.34%
Market Cap8.08B Forward P/E- EPS next Y-0.44 Insider Trans-16.40% Shs Float119.32M Perf Month-2.71%
Income-243.80M PEG- EPS next Q-0.33 Inst Own89.80% Short Float9.88% Perf Quarter44.47%
Sales307.90M P/S26.24 EPS this Y-26.60% Inst Trans0.76% Short Ratio5.27 Perf Half Y38.57%
Book/sh5.68 P/B11.90 EPS next Y63.00% ROA-15.70% Target Price65.50 Perf Year72.74%
Cash/sh8.72 P/C7.75 EPS next 5Y20.00% ROE-20.90% 52W Range36.10 - 71.60 Perf YTD28.68%
Dividend- P/FCF- EPS past 5Y-18.60% ROI-46.30% 52W High-5.56% Beta1.06
Dividend %- Quick Ratio14.90 Sales past 5Y129.90% Gross Margin72.40% 52W Low87.31% ATR2.03
Employees1268 Current Ratio15.30 Sales Q/Q86.60% Oper. Margin-38.80% RSI (14)68.60 Volatility2.59% 3.43%
OptionableYes Debt/Eq0.71 EPS Q/Q-3.10% Profit Margin-38.60% Rel Volume0.49 Prev Close67.61
ShortableYes LT Debt/Eq0.71 EarningsAug 01 AMC Payout- Avg Volume2.24M Price67.62
Recom1.80 SMA206.37% SMA5011.40% SMA20028.03% Volume1,089,760 Change0.01%
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Jul-26-17Reiterated Lake Street Hold $30 → $41
Jul-26-17Reiterated Canaccord Genuity Buy $42 → $45
May-31-17Reiterated The Benchmark Company Buy $34 → $50
May-31-17Reiterated Canaccord Genuity Buy $38 → $40
Apr-17-17Initiated Leerink Partners Outperform $30
Feb-22-17Upgrade ROTH Capital Neutral → Buy
Feb-21-17Upgrade The Benchmark Company Hold → Buy $17 → $27
Nov-01-16Reiterated Lake Street Hold $8 → $15
Oct-26-16Reiterated The Benchmark Company Hold $14 → $17
Jul-27-16Reiterated The Benchmark Company Hold $9 → $14
Jul-27-16Reiterated Mizuho Neutral $10 → $15
Jul-27-16Reiterated Jefferies Buy $13 → $20
Jul-18-18 02:58PM  3 'Strong Buy' Healthcare Stocks Poised to Surge TheStreet.com
Jul-12-18 07:25AM  Free Research Reports on DexCom and Three More Medical Research Stocks ACCESSWIRE
Jul-09-18 04:15PM  Exact Sciences to host annual meeting, second-quarter 2018 results webcasts and calls PR Newswire
Jul-07-18 07:15AM  Why Exact Sciences Shares Are Rallying 13.8% in 2018 Motley Fool
Jun-26-18 11:00AM  Nurse Practitioners are Critical Source of Colorectal Cancer Screening Information for Patients, Survey Shows PR Newswire
07:40AM  Research Report Identifies PDL BioPharma, TEGNA, Patterson Companies, Boardwalk Pipeline Partners, Exact Sciences, and Berkshire Hathaway with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jun-21-18 06:00AM  3 Small Cap Stocks That Can Thrive Amid a Trade War Investopedia
Jun-19-18 09:00AM  Cologuard Challenge Expands to AmFam Championship Urging PGA TOUR Champions Fans to Get Screened for Colon Cancer PR Newswire
08:08AM  Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares Benzinga
Jun-08-18 09:20AM  Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs Benzinga
08:00AM  Exact Sciences Announces Upsizing and Pricing of 1.0% Convertible Senior Notes Due 2025 PR Newswire
Jun-07-18 04:01PM  Exact Sciences Announces Offering of 1.0% Convertible Senior Notes Due 2025 PR Newswire
Jun-06-18 04:10PM  This Biotech Said It Can Detect Liver Cancer In Your Blood And Broke Out Investor's Business Daily
08:38AM  Benzinga's Daily Biotech Pulse: Vascular Biogenics Soars On Positive Platform Data, Axovant Licenses Parkinson's Candidate Benzinga
Jun-05-18 04:30PM  Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma PR Newswire
Jun-04-18 08:09AM  20 Million More Potential Customers for Cologuard: Time to Buy Exact Sciences Stock? Motley Fool
07:10AM  Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks ACCESSWIRE
Jun-01-18 01:28PM  Exact Sciences' Cologuard market expands by 20+ million with new American Cancer Society guidelines American City Business Journals
06:00AM  Exact Sciences to participate in June investor conferences PR Newswire
May-30-18 04:29PM  Why Movado Group, Fiat Chrysler Automobiles, and Exact Sciences Jumped Today Motley Fool +11.12%
03:58PM  Exact Sciences Applauds American Cancer Society's Updated Colorectal Cancer Screening Guidelines to Include People Age 45-49 PR Newswire
03:36PM  This News Explains Exact Sciences' Double-Digit Pop Today Motley Fool
02:57PM  American Cancer Society recommends earlier colorectal cancer screening Reuters
02:54PM  Exact Sciences shares surge 11% on earlier cancer screening recommendation MarketWatch
01:26PM  American Cancer Society recommends earlier colorectal cancer screening Reuters
May-29-18 08:18AM  Where Will Exact Sciences Corporation Be in 5 Years? Motley Fool
May-24-18 08:56PM  Where Exact Sciences Corporation (NASDAQ:EXAS) Stands In Earnings Growth Against Its Industry Simply Wall St.
May-14-18 06:00AM  4 Biotech Stocks Set to Rise By 14% or More Investopedia
May-08-18 07:20AM  Recent Analysis Shows Boardwalk Pipeline Partners, Chegg, CommScope Holding, Exact Sciences, HollyFrontier, and Hecla Mining Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
May-03-18 12:36PM  Exact Sciences teams with Vince Lombardi foundation in fight against colon cancer American City Business Journals
09:00AM  Vince Lombardi Cancer Foundation and Exact Sciences Team Up to Fight Colon Cancer PR Newswire
May-02-18 04:08PM  [$$] Exact Sciences: A Big Opportunity? Barrons.com
May-01-18 06:00AM  Exact Sciences to participate in two investor conferences during May PR Newswire
Apr-30-18 08:43AM  Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher Zacks
Apr-27-18 04:29PM  Why SVB Financial Group, Exact Sciences, and Sprint Jumped Today Motley Fool +11.63%
12:30PM  Why Exact Sciences Is Soaring Today Motley Fool
07:35AM  Edited Transcript of EXAS earnings conference call or presentation 26-Apr-18 9:00pm GMT Thomson Reuters StreetEvents
05:06AM  Exact Sciences: 1Q Earnings Snapshot Associated Press
Apr-26-18 05:11PM  Exact Sciences revenue jumps 87% in first quarter, topping consensus American City Business Journals
04:05PM  Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000 PR Newswire
Apr-25-18 06:02AM  Don't Get Greedy With Exact Sciences Corporation Stock Motley Fool
Apr-13-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Immunomedics ACCESSWIRE
Apr-10-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences and Exelixis ACCESSWIRE
Apr-09-18 06:00AM  Exact Sciences schedules first-quarter 2018 earnings call PR Newswire +6.63%
05:31AM  Exact Sciences Corporation Could Break Out Despite Steep Drop in Biotech InvestorPlace
Apr-08-18 09:31AM  Is Exact Sciences Corp. Still a Buy in 2018? Motley Fool
Apr-06-18 02:53PM  Biotech's Exact Sciences Seen Plunging 25% Investopedia -6.57%
07:40AM  Free Post Earnings Research Report: Exact Sciences Quarterly Revenues Jumped 148.02% ACCESSWIRE
Apr-03-18 03:38PM  BTIG Expects 55% Upside In Exact Sciences Benzinga
Mar-23-18 07:30AM  Biotricity: A Little Known Stock That Could Be The Next AXGN or EXAS ACCESSWIRE
Mar-22-18 03:21PM  Edited Transcript of EXAS earnings conference call or presentation 22-Feb-18 10:00pm GMT Thomson Reuters StreetEvents -6.26%
Mar-20-18 05:19PM  Exact Sciences names president to lead Cologuard product American City Business Journals
08:20AM  Todays Research Reports on Trending Tickers: BeiGene and Exact Sciences ACCESSWIRE
06:34AM  Harry Connick Jr. Hasn't Gotten Investors Jazzed Up About Exact Sciences -- Should They Be? Motley Fool
06:00AM  Mark Stenhouse to join Exact Sciences as President, Cologuard PR Newswire
Mar-19-18 09:00AM  Harry Connick, Jr. and Wife and Cancer Survivor Jill Connick Team Up to Urge People 50 and Older to Get Screened for Colon Cancer PR Newswire -7.82%
Mar-14-18 10:54AM  Exact Sciences Corporations (NASDAQ:EXAS) Profit Outlook Simply Wall St.
Mar-09-18 01:55PM  Exact Sciences finds winning combo in Jerry Kelly and the PGA Tour Champions American City Business Journals
Mar-06-18 08:00PM  Here's Why Exact Sciences Shares Fell 10.3% in February Motley Fool
12:58PM  Steve Mandel Expands Reach in Health Care Space With Exact Sciences GuruFocus.com
07:50AM  Detailed Research: Economic Perspectives on Exact Sciences, KapStone Paper and Packaging, Spirit Realty Capital, KLA-Tencor, New Residential Investment, and Brookdale Senior Living What Drives Growth in Today's Competitive Landscape GlobeNewswire
06:00AM  Mayo Clinic's Dr. Paul Limburg to join Exact Sciences medical leadership PR Newswire
Mar-01-18 02:00PM  Jerry Kelly Issues Cologuard Challenge, Urging Fellow PGA TOUR Champions Players to Get Screened for Colon Cancer PR Newswire
06:00AM  Exact Sciences to participate in March investor conferences PR Newswire
Feb-28-18 03:29PM  Tucson Conquistadores and Cologuard Present Check to Vince Lombardi Cancer Foundation PR Newswire
08:20AM  Todays Research Reports on Trending Tickers: Clovis Oncology and Exact Sciences ACCESSWIRE
Feb-27-18 10:00AM  Exact Sciences Corp. (Nasdaq: EXAS) to Ring The Nasdaq Stock Market Opening Bell Remotely from Tucson, Arizona GlobeNewswire
07:32AM  2 Reasons Exact Sciences Investors Shouldn't Worry -- and 1 Reason They Should Motley Fool
Feb-26-18 07:00AM  More than 1 Million Screened for Colorectal Cancer with Cologuard PR Newswire
06:00AM  Exact Sciences' Nightmare May Get Worse for Investors Investopedia
Feb-23-18 04:48PM  This Biotech's Outlook Is Feeling The Flu Is It Just A 'Blip'? Investor's Business Daily -5.82%
Feb-22-18 05:00PM  Exact Sciences reports 4Q loss Associated Press
04:05PM  Cologuard® revenue increased 168 percent to $266 million PR Newswire
02:15PM  6 Favorite Buys Of A Top-Rated Stock Picker Investopedia
01:00PM  Exact Sciences Corporation to Host Earnings Call ACCESSWIRE
Feb-21-18 08:56AM  Is the Options Market Predicting a Spike in Exact Sciences (EXAS) Stock? Zacks
08:38AM  Why Earnings Season Could Be Great for Exact Sciences (EXAS) Zacks
Feb-08-18 06:00AM  Exact Sciences schedules fourth-quarter, full-year 2017 earnings call PR Newswire -7.49%
Feb-07-18 06:31AM  Could Exact Sciences Corporation Be a Millionaire-Maker Stock? Motley Fool
Feb-01-18 06:00AM  Exact Sciences to participate in Leerink Partners 7th Annual Global Healthcare Conference PR Newswire
Jan-26-18 08:30AM  New Research: Key Drivers of Growth for Coca-Cola Bottling Co. Consolidated, McGrath RentCorp, Exact Sciences, Healthcare Trust of America, Gramercy Property Trust, and Apollo Commercial Real Estate Finance Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-25-18 06:15PM  Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $5.6 million of Shares GuruFocus.com
Jan-24-18 08:20AM  Todays Research Reports on Trending Tickers: Exact Sciences Corporation and Ultragenyx Pharmaceutical ACCESSWIRE
Jan-23-18 07:31AM  These 3 Stocks Have Doubled Investors' Money Motley Fool +7.55%
Jan-20-18 07:35PM  Who Are The Top Investors In Exact Sciences Corporation (NASDAQ:EXAS)? Simply Wall St.
Jan-18-18 09:01AM  The Market In 5 Minutes: Jobless Claims Fall, Walmart Upgrade, Cryptocurrencies Benzinga
Jan-17-18 04:30PM  Why Exact Sciences, A10 Networks, and 3D Systems Slumped Today Motley Fool -9.95%
04:14PM  The Sell-Side Weighs In: Was The Exact Sciences Sell-Off Overdone? Benzinga
03:18PM  Exact Sciences: Wait, It's Not That Bad! Barrons.com
11:20AM  Why Exact Sciences Will Plunge Even Further Investopedia
Jan-15-18 08:10AM  Todays Research Reports on Stocks to Watch: Concert Pharmaceuticals and Exact Sciences Corporation ACCESSWIRE
Jan-12-18 07:00AM  3 Stocks to Watch on Friday: Advanced Micro Devices, Inc. (AMD), EXACT Sciences Corporation (EXAS) and International Business Machines Corp. (IBM) InvestorPlace
Jan-11-18 09:47PM  Exact Sciences Announces Upsize and Pricing of $600 Million of 1.0% Convertible Senior Notes Due 2025 PR Newswire
04:01PM  Exact Sciences Announces Offering of $500 Million Convertible Senior Notes Due 2025 PR Newswire
Jan-10-18 08:37AM  Exact Sciences (EXAS) in Focus: Stock Moves 5.1% Higher Zacks
08:31AM  3 Slides That Paint a Great Picture for Exact Sciences' Future Motley Fool
Jan-09-18 02:57PM  EXACT Sciences: Wait For a Better Buying Opportunity TheStreet.com +5.14%
08:10AM  Todays Research Reports on Stocks to Watch: ACADIA Pharmaceuticals Inc. and Exact Sciences Corporation ACCESSWIRE
08:04AM  See what the IHS Markit Score report has to say about Exact Sciences Corp. Markit
06:41AM  Exact Sciences: Cramer's Top Takeaways TheStreet.com
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COWARD D SCOTTSVP and General CounselJul 02Sale59.102,135126,17673,359Jul 03 04:10 PM
COWARD D SCOTTSVP and General CounselJun 30Option Exercise0.004,687075,494Jul 03 04:10 PM
WYZGA MICHAEL SDirectorMay 10Sale51.537,402381,44710,974May 11 04:48 PM
Zanotti Katherine SDirectorApr 12Sale45.007,232325,440105,814Apr 13 07:06 PM
Doyle James EdwardDirectorApr 10Sale40.973,098126,92535,181Apr 12 04:15 PM
Carey Thomas D.DirectorApr 10Sale39.738,448335,63052,410Apr 12 04:10 PM
COWARD D SCOTTSVP and General CounselApr 02Sale40.122,12285,12467,001Apr 03 04:51 PM
COWARD D SCOTTSVP and General CounselMar 31Option Exercise0.004,688069,123Apr 03 04:51 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 14Option Exercise13.967,16399,995201,112Mar 15 08:58 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 13Sale53.214,464237,529193,949Mar 13 09:37 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 12Sale52.193,961206,740198,413Mar 13 09:37 PM
COWARD D SCOTTSVP and General CounselMar 12Sale52.192,708141,34164,435Mar 13 04:48 PM
Conroy Kevin TPresident and CEOMar 12Sale52.1911,459598,091882,439Mar 13 04:45 PM
ARORA MANEESHCOOMar 12Sale52.195,295276,367645,089Mar 13 04:43 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 09Option Exercise9.8414,550143,203202,374Mar 13 09:37 PM
COWARD D SCOTTSVP and General CounselMar 09Option Exercise0.006,025067,143Mar 13 04:48 PM
Conroy Kevin TPresident and CEOMar 09Option Exercise0.0024,4000893,898Mar 13 04:45 PM
ARORA MANEESHCOOMar 09Option Exercise0.0011,2750650,384Mar 13 04:43 PM
LIDGARD GRAHAM PETERChief Science OfficerMar 09Sale50.946,125312,001193,949Mar 13 09:37 PM
ARORA MANEESHCOOFeb 27Sale44.105,512243,068639,109Feb 28 07:59 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 27Sale43.6116,688727,712198,808Feb 28 07:58 PM
Conroy Kevin TPresident and CEOFeb 27Sale44.109,085400,630869,498Feb 28 04:44 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Option Exercise5.2327,237142,410220,346Feb 28 07:58 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0020,0250878,583Feb 28 04:44 PM
ARORA MANEESHCOOFeb 26Option Exercise0.0012,1500644,621Feb 28 07:59 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Sale42.2218,337774,248206,596Feb 28 07:58 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Sale42.342,982126,25221,012Feb 27 06:22 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 26Sale42.347,178303,902206,596Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 26Sale42.3425,3191,071,956858,558Feb 27 06:19 PM
COWARD D SCOTTSVP and General CounselFeb 26Sale42.344,420187,13449,010Feb 27 06:20 PM
ARORA MANEESHCOOFeb 26Sale42.3412,352522,959632,471Feb 27 06:18 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 24Option Exercise0.008,2500213,774Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0019,5000883,877Feb 27 06:19 PM
ARORA MANEESHCOOFeb 24Option Exercise0.0011,0000644,823Feb 27 06:18 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Option Exercise13.7931,825439,020225,774Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0034,3250864,377Feb 27 06:19 PM
COWARD D SCOTTSVP and General CounselFeb 23Option Exercise0.0012,850053,430Feb 27 06:20 PM
ARORA MANEESHCOOFeb 23Option Exercise0.0018,8750633,823Feb 27 06:18 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.009,300023,994Feb 27 06:22 PM
LIDGARD GRAHAM PETERChief Science OfficerFeb 23Sale39.7720,250805,364205,524Feb 27 06:24 PM
Conroy Kevin TPresident and CEOFeb 09Option Exercise0.83101,48884,235931,540Feb 13 04:09 PM
Conroy Kevin TPresident and CEOFeb 09Sale45.72101,4884,640,272830,052Feb 13 04:09 PM
Conroy Kevin TPresident and CEOJan 23Option Exercise0.83110,43991,664940,491Jan 25 04:10 PM
Conroy Kevin TPresident and CEOJan 23Sale50.49110,4395,575,961830,052Jan 25 04:10 PM
Conroy Kevin TPresident and CEOJan 12Option Exercise0.83125,402104,084955,454Jan 17 04:07 PM
Conroy Kevin TPresident and CEOJan 12Sale52.79125,4026,620,593830,052Jan 17 04:07 PM
COWARD D SCOTTSVP and General CounselJan 03Sale52.541,66587,47440,580Jan 04 05:32 PM
COWARD D SCOTTSVP and General CounselJan 02Option Exercise0.004,687042,245Jan 04 05:32 PM
Conroy Kevin TPresident and CEODec 22Option Exercise0.83123,512102,515953,564Dec 26 04:18 PM
Conroy Kevin TPresident and CEODec 22Sale52.58123,5126,494,790830,052Dec 26 04:18 PM
Conroy Kevin TPresident and CEODec 06Option Exercise0.83121,849101,135951,901Dec 08 04:15 PM
Conroy Kevin TPresident and CEODec 06Sale53.45121,8496,513,179830,052Dec 08 04:15 PM
LIDGARD GRAHAM PETERChief Science OfficerDec 01Sale58.2745,7702,667,204193,949Dec 04 04:23 PM
Conroy Kevin TPresident and CEONov 21Option Exercise0.83134,057111,267964,109Nov 22 04:23 PM
Conroy Kevin TPresident and CEONov 21Sale59.50134,0577,976,660830,052Nov 22 04:23 PM
Conroy Kevin TPresident and CEONov 09Option Exercise0.83137,815114,386967,867Nov 13 04:10 PM
Conroy Kevin TPresident and CEONov 09Sale59.14137,8058,149,669830,052Nov 13 04:10 PM
LIDGARD GRAHAM PETERChief Science OfficerNov 01Sale53.6045,7752,453,768239,719Nov 03 04:13 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 02Option Exercise13.9635,250492,090366,519Oct 03 05:15 PM
LIDGARD GRAHAM PETERChief Science OfficerOct 02Sale47.1681,0253,820,734285,494Oct 03 05:15 PM
COWARD D SCOTTSVP and General CounselOct 02Sale47.1629,1151,373,11535,876Oct 03 05:14 PM
COWARD D SCOTTSVP and General CounselSep 29Option Exercise0.004,688064,991Oct 03 05:14 PM
LIDGARD GRAHAM PETERChief Science OfficerSep 06Option Exercise9.4542,317399,989331,269Sep 07 05:32 PM
LIDGARD GRAHAM PETERChief Science OfficerSep 05Option Exercise11.4775,683868,356364,635Sep 07 05:32 PM
LIDGARD GRAHAM PETERChief Science OfficerSep 05Sale40.8175,6833,088,801288,952Sep 07 05:32 PM
LIDGARD GRAHAM PETERChief Science OfficerSep 01Sale41.4945,7751,899,205288,952Sep 05 04:10 PM
THOMPSON DAVIDDirectorAug 28Option Exercise6.0652,472318,121196,444Aug 30 04:47 PM
Conroy Kevin TPresident and CEOAug 17Option Exercise10.829,24299,998830,052Aug 17 05:09 PM
Carey Thomas D.DirectorAug 17Buy37.712,50094,27560,858Aug 18 04:07 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 31Sale39.415,846230,39114,015Aug 01 04:18 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 28Option Exercise0.0018,750019,861Aug 01 04:18 PM